IS THE PATIENT PARTNERSHIP INFORMATIVE IN PHARMACOVIGILANCE?
Open Access
- 29 September 2017
- journal article
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 55 (4), 449-451
- https://doi.org/10.14412/1995-4484-2017-449-451
Abstract
The paper discusses whether patients' spontaneous reporting on adverse drug reactions is appropriate and possible.Keywords
This publication has 30 references indexed in Scilit:
- New EU drug safety committee ends national reporting of drug reactionsBMJ, 2012
- Adverse Drug Reactions: Part ISouthern Medical Journal, 2010
- Consumer Reporting of Adverse Drug ReactionsDrug Safety, 2009
- Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, NigeriaBMC Clinical Pharmacology, 2009
- Hospital Admissions Associated with Adverse Drug Reactions: A Systematic Review of Prospective Observational StudiesAnnals of Pharmacotherapy, 2008
- Application of Quantitative Signal Detection in the Dutch Spontaneous Reporting System for Adverse Drug ReactionsDrug Safety, 2003
- Analysis of the direct cost of adverse drug reactions in hospitalised patientsEuropean Journal of Clinical Pharmacology, 2001
- Adverse drug reactions: definitions, diagnosis, and managementThe Lancet, 2000
- Incidence of Adverse Drug Reactions in Hospitalized PatientsJAMA, 1998
- Incidence of Adverse Drug Events and Potential Adverse Drug EventsJAMA, 1995